ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Aveanna Healthcare prices $176.25m secondary offering at $11.75 per share

Secondary sale of 15 million shares priced at $11.75 each, with proceeds going to selling stockholders including J.H. Whitney affiliates. RBC Capital Markets leads book-running.

PA
Priya Anand · Equities & Earnings Desk · 21 Aug 2026 · 07:55 · 1 min read
Share
Aveanna Healthcare prices $176.25m secondary offering at $11.75 per share

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) has priced a secondary offering of 15 million shares of common stock at $11.75 per share, raising approximately $176.25 million in gross proceeds.

The offering is being conducted by certain selling stockholders, including affiliates of J.H. Whitney Equity Partners VII, LLC, as well as current and former directors and officers of the company. Aveanna Healthcare itself is not issuing or selling any shares and will not receive any proceeds from the transaction.

RBC Capital Markets is serving as the sole book-running manager for the offering, which includes a 30-day option for the underwriter to purchase up to an additional 2.25 million shares. The deal is expected to settle on August 24, 2026, subject to customary closing conditions.

The company, headquartered in Atlanta, operates in 39 states, providing pediatric and adult healthcare services primarily in home settings. Its services include nursing, hospice, rehabilitation, occupational nursing in schools, therapy, and day treatment center operations. The offering follows a shelf registration statement on Form S-3, which has been filed with and declared effective by the U.S. Securities and Exchange Commission.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT